Heroin Use and Risk of Infectious Disease
By Lauren Gilmore
Researchers who have studied the patterns of noninjecting
heroin users have discovered that they are at high risk for becoming
intravenous users in the future. Many heroin addicts who prefer
snorting and smoking methods believe that they can avoid serious
risks that accompany injection use. Researchers at the National
Development and Research Institutes (NDRI) focused on the transition
rates of noninjection users to injection users as well as other
consequences of abusing heroin.
Dr. Neaigus and colleagues of the NDRI recruited
560 noninjecting heroin users to participate in the study. The
participants consisted of heroin users who had no history of injecting
drugs, as well as former injection users who had not injected
drugs in at least six months. Data was obtained from follow-up
interviews conducted with 331 participants. Among these participants,
15 percent had transitioned from snorting/smoking methods to injection
use. A comparison of data on subjects who were former intravenous
users and subjects with no history of intravenous use yielded
no significant difference.
Past studies have revealed higher transition rates from noninjection
to injection use, especially among former injectors. Dr. Neagius
believes that certain factors may slow down the transition rate.
During the 1990's the purity of heroin increased,
which causes a more intense "high," similar to the euphoria
one would achieve with injection. Therefore, researchers believe
that a lot of users were satisfied with the snorting and smoking
methods and didn't feel the need to resort to intravenous use.
A second factor is the AIDS epidemic. People are more cautious
and aware of the possible risk associated with contracting the
disease by means of intravenous use.
Some studies have focused on the factors that do increase transition
Earlier research findings suggest that noninjecting
users who associate, have sexual relations, and/or use drugs with
intravenous users are at a higher risk for transitioning. In addition
to association, exposure to intravenous use may also influence
a noninjecting user. Another factor is the extent of the addiction.
A study conducted by NIDR's Dr. Friedman completed follow-up interviews
with 755 noninjecting users. The data revealed that 30 percent
of the subjects admitted to transition, reporting that it was
a better high. Similar studies have shown that, even with the
availability of highly pure heroin, the more chronic users transition
to intravenous use because it is a more effective method.
Infectious diseases are a huge concern among users.
There are many risks that accompany drug abuse, despite method
of use. Dr. Neaigus found that 23 percent of noninjecting users
who transitioned to intravenous use developed hepatitis C (HCV).
HCV can lead to liver infection as well as fatal liver diseases
such as cancer and cirrhosis. Around 9.5 percent developed hepatitis
B (HBV) which can also lead to liver infections and diseases.
Sexual transmission of HBV was more common among the noninjecting
users with no history of intravenous use who had transitioned
during the study. No cases of HIV transmission were reported.
However, the high rates of HBV and HCV transmission, suggest that
the sexual behaviors and injection patterns put these groups at
Dr. Neaigus concludes that intravenous users who
transition to alternative methods such as snorting and smoking
greatly reduce their chances of infectious disease transmission.
The opposite is true for noninjecting users who transition to
intravenous use; they greatly increase their chances of infectious
disease transmission, as well as developing serious health problems.
Adapted from NIDA Notes, Volume 14(2), U.S. Department of Health
and Human Services, National Institute of Health
(Neaigus, A., et al. Trends in the noninjected use of heroin
and factors associated with the transition to injecting. In J.A.
Inciardi and L.D. Harrison (eds._, Heroin in the Age of Crack
Cocaine, Thousand Oaks, CA: Sage Publications, Inc., pp. 131-159,